For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
The global Auto-Injectors market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.
This report provides detailed historical analysis of global market for Auto-Injectors from 2014-2019, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Auto-Injectors market.
Leading players of Auto-Injectors including:
- Johnson & Johnson
- Amgen Inc.
- Eli Lilly
- Biogen Idec
- Meridian (Pfizer)
- Ypsomed Holding
- Kaleo, Inc.
- Owen Mumford
- Antares Pharma, Inc.
- Medeca Pharma AB
Market split by Type, can be divided into:
- Disposable Auto-Injectors
- Reusable Auto-Injectors
Market split by Application, can be divided into:
- Multiple Sclerosis
- Rheumatoid Arthritis
Market split by Sales Channel, can be divided into:
- Direct Channel
- Distribution Channel
Market segment by Region/Country including:
- North America (United States, Canada and Mexico)
- Europe (Germany, UK, France, Italy, Russia and Spain etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
- South America Brazil, Argentina, Colombia and Chile etc.)
- Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)
If you have any special requirement, please let us know and we can provide you the report as your requirement.